NO820979L - Fremgangsmaate for fremstilling av pyridinderivater - Google Patents

Fremgangsmaate for fremstilling av pyridinderivater

Info

Publication number
NO820979L
NO820979L NO820979A NO820979A NO820979L NO 820979 L NO820979 L NO 820979L NO 820979 A NO820979 A NO 820979A NO 820979 A NO820979 A NO 820979A NO 820979 L NO820979 L NO 820979L
Authority
NO
Norway
Prior art keywords
procedure
pyridine derivatives
preparing pyridine
preparing
derivatives
Prior art date
Application number
NO820979A
Other languages
English (en)
Other versions
NO159850B (no
NO159850C (no
Inventor
Philippe Manoury
Jean Binet
Icilio Cavero
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO820979L publication Critical patent/NO820979L/no
Publication of NO159850B publication Critical patent/NO159850B/no
Publication of NO159850C publication Critical patent/NO159850C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO820979A 1981-03-25 1982-03-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater. NO159850C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8106005A FR2502618A1 (fr) 1981-03-25 1981-03-25 Derives de pyridine, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NO820979L true NO820979L (no) 1982-09-27
NO159850B NO159850B (no) 1988-11-07
NO159850C NO159850C (no) 1989-02-15

Family

ID=9256643

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820979A NO159850C (no) 1981-03-25 1982-03-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater.

Country Status (20)

Country Link
US (1) US4406907A (no)
EP (1) EP0061379B1 (no)
JP (1) JPS57169462A (no)
AR (1) AR231281A1 (no)
AT (1) ATE15895T1 (no)
AU (1) AU545747B2 (no)
CA (1) CA1185978A (no)
DE (1) DE3266607D1 (no)
DK (1) DK156652C (no)
ES (1) ES8303346A1 (no)
FI (1) FI75808C (no)
FR (1) FR2502618A1 (no)
GR (1) GR75930B (no)
HU (1) HU186488B (no)
IE (1) IE52654B1 (no)
IL (1) IL65336A (no)
MX (1) MX156114A (no)
NO (1) NO159850C (no)
NZ (1) NZ200118A (no)
ZA (1) ZA822008B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6218598A (en) * 1997-01-30 1998-08-25 Synthelabo Alpha-azacyclomethyl benzothiophene and alpha-azacyclomethyl benzofurane derivatives, preparation and therapeutic application
FR2758820B1 (fr) * 1997-01-30 1999-02-26 Synthelabo Derives de alpha-azacyclomethyl-benzofurane, leur preparation et leur application en therapeutique
CN113490670B (zh) 2019-08-05 2023-06-02 北京志健金瑞生物医药科技有限公司 含氮多环稠环类化合物,其药物组合物、制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195090A (en) * 1973-02-20 1980-03-25 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
AR206801A1 (es) * 1973-02-20 1976-08-23 Ciba Geigy Ag Procedimiento para la elaboracion de derivados del 1-pirid loxi-2-hidroxi-3-amino-propano

Also Published As

Publication number Publication date
ES510724A0 (es) 1983-02-01
AU8187382A (en) 1982-09-30
IL65336A (en) 1985-08-30
IE820682L (en) 1982-09-25
JPS57169462A (en) 1982-10-19
FI821034A0 (fi) 1982-03-24
FR2502618A1 (fr) 1982-10-01
HU186488B (en) 1985-08-28
EP0061379A1 (fr) 1982-09-29
AU545747B2 (en) 1985-08-01
ZA822008B (en) 1983-02-23
DK156652C (da) 1990-02-05
US4406907A (en) 1983-09-27
FI821034L (fi) 1982-09-26
DK133282A (da) 1982-09-26
MX156114A (es) 1988-07-12
FR2502618B1 (no) 1983-12-23
IE52654B1 (en) 1988-01-06
CA1185978A (en) 1985-04-23
NO159850B (no) 1988-11-07
FI75808C (fi) 1988-08-08
FI75808B (fi) 1988-04-29
NO159850C (no) 1989-02-15
NZ200118A (en) 1984-09-28
ES8303346A1 (es) 1983-02-01
AR231281A1 (es) 1984-10-31
ATE15895T1 (de) 1985-10-15
GR75930B (no) 1984-08-02
IL65336A0 (en) 1982-05-31
EP0061379B1 (fr) 1985-10-02
JPS6135185B2 (no) 1986-08-12
DE3266607D1 (en) 1985-11-07
DK156652B (da) 1989-09-18

Similar Documents

Publication Publication Date Title
NO850300L (no) Fremgangsmaate for fremstilling av 3-imidazolylmetyl-tetrahydrokarbazolon-derivater
NO822216L (no) Fremgangsmaate for fremstilling av bromhexin-retardform
NO851921L (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifanycin-derivater.
NO820253L (no) Fremgangsmaate for fremstilling av furo-(3,4-c)pyridin-derivater
NO810610L (no) Fremgangsmaate for fremstilling av piperidinderivater
NO813208L (no) Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater.
NO851466L (no) Fremgangsmaate for fremstilling av 9a-aza-9a-homoery-tromycin-derivater.
NO822510L (no) Fremgangsmaate til fremstilling av pyridazinderivater
NO813442L (no) Fremgangsmaate for fremstilling av 2-guanidin-4-heteroaryltiazolderivater
DK592183D0 (da) Pyridinderivater
FI822464A0 (fi) Benzotiazolsulfonamidderivat foer lokal behandling av oekat intraokulaert tryck
NO823637L (no) Fremgangsmaate for fremstilling av eburnamoninderivater
NO820980L (no) Fremgangsmaate for fremstilling av imidazo-pyrimidin-derivater
DK505482A (da) Fremgangsmaade til fremstilling af pyridinderivater
NO791604L (no) Fremangsmaate for fremstilling av di-o-n-alkyl-glycerolderivater
NO812841L (no) Fremgangsmaate til fremstilling av florerte pentendiaminderivater
NO851550L (no) Fremgangsmaate for fremstilling av imidazolderivater
FI830891A7 (fi) Menetelmä pyridiinijohdannaisten valmistamiseksi.
NO845038L (no) Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydrotiazolo(5,4-c)pyridin-derivater
NO165107C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
NO841965L (no) Fremgangsmaate for fremstilling av 1,8-dihydroksy-10-acyl-9-antron-derivater
NO845016L (no) Fremgangsmaate ved fremstilling av substituerte spiropyridinderivater
NO803051L (no) Fremgangsmaate for fremstilling av pyridinderivater
NO844466L (no) Fremgangsmaate for fremstilling av pyrimidoisokinolin-derivater
RO82034A (ro) Procedeu pentru prepararea 3-picolinei